In silico Clinical Trials: A New Dawn in Biomedical Research?

In silico Clinical Trials: A New Dawn in Biomedical Research?

Nowadays, scientific knowledge seems to be increasingly generated using technological methods, but also governed by technological demands and conducted by new technical ways of learning. In this paper I will analyze an effective example of this new trend in biomedical research: the Avicenna project...

Full description

Bibliographic Details
Main Author:	Ilaria Malagrinò
Format:	Article
Language:	English
Published:	Associazione Culturale Humana.Mente 2016-06-01
Series:	Humana.Mente: Journal of Philosophical Studies
Subjects:	in silico clinical trials embodied subjectivity scientific knowledge
Online Access:	http://www.humanamente.eu/index.php/HM/article/view/61

Similar Items

In-Silico Trials for Treatment of Acute Ischemic Stroke
by: Praneeta R. Konduri, et al.
Published: (2020-09-01)

In silico imaging clinical trials: cheaper, faster, better, safer, and more scalable
by: Aldo Badano
Published: (2021-01-01)

Food and COVID-19: Preventive/Co-therapeutic Strategies Explored by Current Clinical Trials and in Silico Studies
by: Giacomo Di Matteo, et al.
Published: (2020-08-01)

Unapproved clinical trials in Russia: exception or norm?
by: Petr Talantov, et al.
Published: (2021-04-01)

In Silico Medicine: The Practitioners’ Points of View Medicine: The Practitioners’ Points of View Medicine:
by: Matteo Cerri, et al.
Published: (2016-06-01)

Synergistic Effects of Sanghuang–Danshen Bioactives on Arterial Stiffness in a Randomized Clinical Trial of Healthy Smokers: An Integrative Approach to in silico Network Analysis
by: Yeni Lim, et al.
Published: (2019-01-01)

Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB
by: Giulia Russo, et al.
Published: (2020-12-01)

Clinical trial transparency at McGill University
by: Richeek Pradhan, et al.
Published: (2020-07-01)

In Silico Pharmacy: From Computations to Clinics
by: Mehdi Soleimani, et al.
Published: (2018-05-01)

Clinical trials during the COVID-19 pandemic: Challenges of putting scientific and ethical principles into practice
by: Arun Bhatt
Published: (2020-01-01)

The COVID-19 pandemic and new clinical trial activations
by: Joseph M. Unger, et al.
Published: (2021-04-01)

In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform
by: Giulia Russo, et al.
Published: (2020-12-01)

Study of the trial subjects’ protection aspects in Phase I clinical trials and bioequivalence studies
by: K. O. Zupanets, et al.
Published: (2016-03-01)

Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines
by: Rajarshi Ghosh, et al.
Published: (2017-11-01)

Development of Clinical Trials in Turkey After the Adoption of Clinical Drug Research Regulation
by: Fatih Özdener, et al.
Published: (2020-06-01)

Impact Assessment of Clinical Trials on Knowledge Production and Development in Iran
by: M Feizabadi, et al.
Published: (2016-10-01)

Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity
by: Elisa Passini, et al.
Published: (2017-09-01)

Knowledge and perception regarding clinical trials among doctors of government medical colleges: A questionnaire-based study
by: Supriyo Choudhury, et al.
Published: (2016-01-01)

Exploring the Potential of Generative Adversarial Networks for Synthesizing Radiological Images of the Spine to be Used in In Silico Trials
by: Fabio Galbusera, et al.
Published: (2018-05-01)

Digital clinical trial: A new norm in clinical research
by: Sayanta Thakur, et al.
Published: (2021-01-01)

Phase I (first-in-man) prophylactic vaccine′s clinical trials: Selecting a clinical trial site
by: Shantanu Mehta, et al.
Published: (2015-01-01)

A Case-Control Comparison of Retracted and Non-Retracted Clinical Trials: Can Retraction Be Predicted?
by: R. Grant Steen, et al.
Published: (2014-01-01)

Survey Of Blinding Methods, Type Of Intervention And Subject Areas In Randomized Controlled Clinical Trials
by: Roohangiz Jamshidi Orak, et al.
Published: (2013-01-01)

Survey Of Blinding Methods, Type Of Intervention And Subject Areas In Randomized Controlled Clinical Trials
by: Roohangiz Jamshidi Orak, et al.
Published: (2013-01-01)

Blinded In Silico Drug Trial Reveals the Minimum Set of Ion Channels for Torsades de Pointes Risk Assessment
by: Xin Zhou, et al.
Published: (2020-01-01)

Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications
by: Moses Fung, et al.
Published: (2017-05-01)

Modeling-Based Decision Support System for Radical Prostatectomy Versus External Beam Radiotherapy for Prostate Cancer Incorporating an <i>In Silico</i> Clinical Trial and a Cost–Utility Study
by: Yvonka van Wijk, et al.
Published: (2021-05-01)

Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN)
by: C. Madeira, et al.
Published: (2016-12-01)

Supplemented Alkaline Phosphatase Supports the Immune Response in Patients Undergoing Cardiac Surgery: Clinical and Computational Evidence
by: Alva Presbitero, et al.
Published: (2018-10-01)

Pneumomediastinum with subcutaneous emphysema in a silico tuberculosis patient
by: Dixit Ramakant, et al.
Published: (2007-01-01)

In Silico Modeling: the Human Factor
by: Marta Bertolaso, et al.
Published: (2016-06-01)

Strategies to exclude subjects who conceal and fabricate information when enrolling in clinical trials
by: Eric G. Devine, et al.
Published: (2017-03-01)

State and problems of clinical trials in Russian Federation
by: A A Kuzmin
Published: (2016-12-01)

Updated analysis of pediatric clinical studies registered in ClinicalTrials.gov, 2008–2019
by: Yang Zhong, et al.
Published: (2021-04-01)

In silico toxicology – non-testing methods
by: Hannu eRaunio
Published: (2011-06-01)

Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews
by: Edgardo Rodríguez-Torres, et al.
Published: (2021-09-01)

Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov—evaluation of a new tracking tool for the US clinical trial registry
by: Sarai Mirjam Keestra, et al.
Published: (2021-06-01)

Application of critical path analysis in clinical trials
by: Amal Kumar, et al.
Published: (2016-01-01)

In vitro and in silico Approaches to the Identification of New Compounds with Antibacterial Profile
by: Carlos R. Rodrigues, et al.
Published: (2013-06-01)

Data on global analysis of clinical trials with probiotics
by: Theresia M.G. Dronkers, et al.
Published: (2020-10-01)

Cannot write session to /tmp/vufind_sessions/sess_f9bqvuu8rmmhdbk3998u4qgm3f